Risperdal News and Research

RSS
Alkermes reports financial results for first quarter of 2014

Alkermes reports financial results for first quarter of 2014

State highlights: State mental hospitals compared to prisons; Johnson & Johnson ruling; Va. hospitals pick new leader

State highlights: State mental hospitals compared to prisons; Johnson & Johnson ruling; Va. hospitals pick new leader

First Edition: April 8, 2014

First Edition: April 8, 2014

State highlights: Ark. court reverses $1.2B Medicaid drug judgment; Fla. officials overhauling child welfare agency

State highlights: Ark. court reverses $1.2B Medicaid drug judgment; Fla. officials overhauling child welfare agency

First Edition: March 21, 2014

First Edition: March 21, 2014

Janssen Pharmaceuticals to pay over $1.6 billion in drug misbranding case

Janssen Pharmaceuticals to pay over $1.6 billion in drug misbranding case

Alkermes reports 38% of year-over-year revenue growth from key products

Alkermes reports 38% of year-over-year revenue growth from key products

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

State highlights: Ark. AG asks state Supreme Court to uphold J&J fine; N.Y. abortion measure to get separate vote

State highlights: Ark. AG asks state Supreme Court to uphold J&J fine; N.Y. abortion measure to get separate vote

First Edition: June 19, 2013

First Edition: June 19, 2013

State roundup: Minn. officials want money for coverage expansion

State roundup: Minn. officials want money for coverage expansion

Off label atypical antipsychotic use lacks safety and effectiveness in patients over 40

Off label atypical antipsychotic use lacks safety and effectiveness in patients over 40

La. panel kills health exchange plan; Kansas enacts another abortion hurdle; Utah official resigns after medical records breach

La. panel kills health exchange plan; Kansas enacts another abortion hurdle; Utah official resigns after medical records breach

Newly diagnosed schizophrenia patients continue to use oral Abilify as first-line therapy

Newly diagnosed schizophrenia patients continue to use oral Abilify as first-line therapy

Feds ask court to 'force' J&J executive to testify in lawsuit alleging kickbacks and Medicaid fraud

Feds ask court to 'force' J&J executive to testify in lawsuit alleging kickbacks and Medicaid fraud

Johnson & Johnson fined $1.2B for hiding anti-psychotic drug dangers, deceptive marketing

Johnson & Johnson fined $1.2B for hiding anti-psychotic drug dangers, deceptive marketing

First Edition: April 12, 2012

First Edition: April 12, 2012

N.Y. seeking Medicaid waiver; Calif. adult services lawsuit now 'unsettled'

N.Y. seeking Medicaid waiver; Calif. adult services lawsuit now 'unsettled'

Feds reject J & J's $1 billion drug settlement

Feds reject J & J's $1 billion drug settlement

Weight gain or loss may also depend on medicines taken

Weight gain or loss may also depend on medicines taken